BSE Code: | NSE Code: | ISIN: | Sector:
Research Report Detail
|Report Date||Call||Price@Call||Target Price
|Current Status||Time Horizon|
|Target Hit|| Long (1Y)
Citi upgrades Cadila Healthcare to buy
Citi has upgraded Cadila Healthcare to buy with target of Rs 440. US compliance issues appear to be drawing to a close and strong drug pipeline and execution can drive growth, Citi said.